Exact Sciences Corp (EXAS) Reports In-Line Q3 EPS Loss of $0.15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Loss from operations: -38.28M
Today's EPS Names:
CFFI, ZGN, SSNC, More
Financial Fact:
Loss from operations: -38.28M
Today's EPS Names:
CFFI, ZGN, SSNC, More
Join SI Premium – FREE
Exact Sciences Corp (NASDAQ: EXAS) reported Q3 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $1.03 million versus the consensus estimate of $1.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Packaging Corp. (PKG) Tops Q3 EPS by 12c
- Qiagen posts $548M in Q3 2026 net sales amid pending EQT deal
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
